-
Advancing Clinical Decision Support: Evaluating the Medical Reasoning Capabilities of OpenAI’s o1-Preview Model
19 Dec 2024 23:34 GMT
… foundation models, have significantly outperformed medical professionals in diagnostic benchmarks, with … improvement.
The study evaluated o1-preview’s diagnostic capabilities using New England Journal of Medicine (NEJM) cases …
-
Major study shines spotlight on AI healthcare bias
19 Dec 2024 12:09 GMT
… in The Lancet Digital Health and NEJM AI, the ‘STANDING … , INclusivity and Generalisability)’ study involved more than 350 … Helping anyone who publishes healthcare datasets to identify any … data
Enabling those developing medical AI technologies to assess …
-
New recommendations to increase transparency and tackle potential bias in medical AI technologies
19 Dec 2024 03:42 GMT
… in The Lancet Digital Health and NEJM AI aims to … :
Encouraging medical AI to be developed using appropriate healthcare datasets that … and Chief Investigator of the study said:
"Data … commentary published in Nature Medicine written by the STANDING …
-
Tackling Potential Bias in Medical AI Technologies
18 Dec 2024 17:40 GMT
… in The Lancet Digital Health and NEJM AI aims to … part of a research study involving more than 350 … :
Encouraging medical AI to be developed using appropriate healthcare datasets that … commentary published in Nature Medicine written by the STANDING Together …
-
Caffeine is everywhere. Is it actually harmless?
22 Dec 2024 10:43 GMT
… 2012 study published in the New England Journal of Medicine following a group of coffee …
-
Easing the burden post-mammogram
22 Dec 2024 00:01 GMT
… new study published in the New England Journal of Medicine examines whether removing lymph nodes …
-
Obe-cel Elicits Durable Responses in Relapsed/Refractory B-Cell ALL
21 Dec 2024 23:18 GMT
… (NCT04404660) study published in the New England Journal of Medicine.
Data reveal that the overall …
-
New childhood leukemia protocol — researched with help from Children’s Hospital Colorado — is “tremendous win”
21 Dec 2024 16:51 GMT
… .
The breakthrough, described in a New England Journal of Medicine paper and presented at a …
-
"100% successful" cancer drug gets landmark FDA approval
21 Dec 2024 13:01 GMT
… can be found in The New England Journal of Medicine. Dorstarlimab, a programmed death receptor …
-
Pharma Fridays — December 20, 2024
20 Dec 2024 20:10 GMT
… the discovery and development of medications to treat severe endocrinologic, … Phase 3 Balance study were previously published in The New England Journal of Medicine (NEJM).
“With no … enzyme lipoprotein lipase (LPL). While healthy levels for adults are below …